End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49,800 KRW | -1.19% |
|
-4.23% | -30.83% |
03/05 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
28/03 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.83% | 2.75B | |
+1.87% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+75.16% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- SK Biopharmaceuticals Swings to Loss in Q4